You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

post autologous stem cell transplantation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
May 4, 2022

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

    Active, not recruiting
    Has Results
    • Multiple Myeloma
    • Ixazomib
    • +2 more
    • Duarte, California
    • +9 more
    Jan 11, 2023

    Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
    • (no location specified)
    Oct 30, 2023

    Multiple Myeloma Trial in Philadelphia (CART-19 cells)

    Terminated
    Has Results
    • Multiple Myeloma
    • CART-19 cells
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 4, 2023

    Relapsed Diffuse Large B-cell Lymphoma Trial in Detroit (loncastuximab tesirine)

    Recruiting
    • Relapsed Diffuse Large B-cell Lymphoma
    • loncastuximab tesirine
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Jun 24, 2022

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Non Hodgkin Lymphoma, Follicular Lymphoma, Indolent Lymphoma Trial in Miami, Baltimore, Milwaukee (Zydelig)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • +8 more
    • Miami, Florida
    • +2 more
    Apr 21, 2022

    Multiple Myeloma, Lymphoma Trial in Washington, Hackensack (Ipilimumab, Nivolumab)

    Active, not recruiting
    • Multiple Myeloma
    • Lymphoma
    • Washington, District of Columbia
    • +1 more
    Dec 2, 2021

    Beta-Thalassemia Trial (CS-101 injection)

    Not yet recruiting
    • Beta-Thalassemia
    • CS-101 injection
    • (no location specified)
    Sep 27, 2023

    Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Nov 21, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Tagraxofusp-erzs)

    Active, not recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • Tagraxofusp-erzs
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 8, 2022

    Premature Ovarian Failure Trial in Ulaanbaatar (stem cell therapy)

    Not yet recruiting
    • Premature Ovarian Failure
    • stem cell therapy
    • Ulaanbaatar, Mongolia
      Mongolian National University of Medical Science
    Nov 13, 2023

    Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

    Active, not recruiting
    • Hematopoietic Cell Transplantation Recipient
    • Plasma Cell Myeloma
    • Ixazomib Citrate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 8, 2022

    Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

    Not yet recruiting
    • Multiple Myeloma
    • Stem Cell Transplant Complications
    • PARE
    • Waitlist Control Group
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 30, 2023

    B-cell Lymphoma Trial in Xuzhou (ASCT+CAR-T Cell Infusion)

    Recruiting
    • B-cell Lymphoma
    • ASCT+CAR-T Cell Infusion
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (biological, drug, other)

    Active, not recruiting
    • Hematopoietic Cell Transplantation Recipient
    • Plasma Cell Myeloma
    • Elotuzumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

    Not yet recruiting
    • Autologous Stem Cell Transplantation
    • Conditioning
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xian Jiaotong University
    Apr 14, 2023

    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,

    Active, not recruiting
    Has Results
    • Stage I Multiple Myeloma
    • +2 more
    • Chicago, Illinois
    • +4 more
    Sep 3, 2022

    Spinal Cord Injuries Trial in Salvador (Mesenchymal stem cell transplantation, Placebo)

    Not yet recruiting
    • Spinal Cord Injuries
    • Mesenchymal stem cell transplantation
    • Placebo
    • Salvador, Bahia, Brazil
      Senai Cimatec
    Jan 10, 2023

    Multiple Myeloma Trial in Tianjin (Autologous hematopoietic stem cell transplantation, C-CAR088)

    Recruiting
    • Multiple Myeloma
    • Autologous hematopoietic stem cell transplantation
    • C-CAR088
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Nov 21, 2022

    Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in

    Completed
    Has Results
    • Contiguous Stage II Mantle Cell Lymphoma
    • +5 more
    • Duarte, California
    • +1 more
    Jan 12, 2022

    Parkinson's Disease Trial in Beijing (Autologous induced neural stem cell-derived DA precursor cells)

    Recruiting
    • Parkinson's Disease
    • Autologous induced neural stem cell-derived DA precursor cells
    • Beijing, Beijing, China
      Xuanwu Hospital Capital Medical University
    Jun 13, 2023

    Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

    Recruiting
    • Haploidentical Hematopoietic Stem Cell Transplantation
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Sep 11, 2023

    Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

    Active, not recruiting
    • Plasma Cell Leukemia
    • +3 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022